vs
雅培（ABT）与美国再保险集团（RGA）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是美国再保险集团的1.7倍（$11.5B vs $6.6B），雅培净利率更高（15.5% vs 7.0%，领先8.5%），美国再保险集团同比增速更快（26.6% vs 4.4%），过去两年雅培的营收复合增速更高（7.2% vs 2.3%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
美国再保险集团（RGA）是总部位于美国密苏里州大圣路易斯地区西郊切斯特菲尔德的全球人寿与健康再保险控股集团。截至2024年12月31日，集团有效人寿再保额约3.9万亿美元，总资产达1187亿美元，是全球唯一主营人寿及健康相关再保险业务的国际企业。
ABT vs RGA — 直观对比
营收规模更大
ABT
是对方的1.7倍
$6.6B
营收增速更快
RGA
高出22.2%
4.4%
净利率更高
ABT
高出8.5%
7.0%
两年增速更快
ABT
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $6.6B |
| 净利润 | $1.8B | $463.0M |
| 毛利率 | 57.0% | — |
| 营业利润率 | 19.6% | 7.7% |
| 净利率 | 15.5% | 7.0% |
| 营收同比 | 4.4% | 26.6% |
| 净利润同比 | -80.8% | 212.8% |
| 每股收益（稀释后） | $1.01 | $6.91 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTRGA
| Q4 25 | $11.5B | $6.6B | ||
| Q3 25 | $11.4B | $6.2B | ||
| Q2 25 | $11.1B | $5.6B | ||
| Q1 25 | $10.4B | $5.3B | ||
| Q4 24 | $11.0B | $5.2B | ||
| Q3 24 | $10.6B | $5.7B | ||
| Q2 24 | $10.4B | $4.9B | ||
| Q1 24 | $10.0B | $6.3B |
净利润ABTRGA
| Q4 25 | $1.8B | $463.0M | ||
| Q3 25 | $1.6B | $253.0M | ||
| Q2 25 | $1.8B | $180.0M | ||
| Q1 25 | $1.3B | $286.0M | ||
| Q4 24 | $9.2B | $148.0M | ||
| Q3 24 | $1.6B | $156.0M | ||
| Q2 24 | $1.3B | $203.0M | ||
| Q1 24 | $1.2B | $210.0M |
毛利率ABTRGA
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | 55.2% | — |
营业利润率ABTRGA
| Q4 25 | 19.6% | 7.7% | ||
| Q3 25 | 18.1% | 5.2% | ||
| Q2 25 | 18.4% | 6.1% | ||
| Q1 25 | 16.3% | 7.0% | ||
| Q4 24 | 17.4% | 4.3% | ||
| Q3 24 | 17.5% | 3.8% | ||
| Q2 24 | 16.1% | 5.5% | ||
| Q1 24 | 13.9% | 4.3% |
净利率ABTRGA
| Q4 25 | 15.5% | 7.0% | ||
| Q3 25 | 14.5% | 4.1% | ||
| Q2 25 | 16.0% | 3.2% | ||
| Q1 25 | 12.8% | 5.4% | ||
| Q4 24 | 84.1% | 2.8% | ||
| Q3 24 | 15.5% | 2.8% | ||
| Q2 24 | 12.5% | 4.2% | ||
| Q1 24 | 12.3% | 3.3% |
每股收益（稀释后）ABTRGA
| Q4 25 | $1.01 | $6.91 | ||
| Q3 25 | $0.94 | $3.81 | ||
| Q2 25 | $1.01 | $2.70 | ||
| Q1 25 | $0.76 | $4.27 | ||
| Q4 24 | $5.26 | $2.21 | ||
| Q3 24 | $0.94 | $2.33 | ||
| Q2 24 | $0.74 | $3.03 | ||
| Q1 24 | $0.70 | $3.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $4.2B |
| 总债务越低越好 | $12.9B | $5.7B |
| 股东权益账面价值 | $52.1B | $13.5B |
| 总资产 | $86.7B | $156.6B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资ABTRGA
| Q4 25 | $8.9B | $4.2B | ||
| Q3 25 | $7.7B | $4.6B | ||
| Q2 25 | $7.3B | $5.4B | ||
| Q1 25 | $6.8B | $5.2B | ||
| Q4 24 | $8.0B | $3.3B | ||
| Q3 24 | $7.8B | $5.2B | ||
| Q2 24 | $7.2B | $4.6B | ||
| Q1 24 | $6.7B | $5.9B |
总债务ABTRGA
| Q4 25 | $12.9B | $5.7B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | — | $5.7B | ||
| Q1 25 | — | $5.7B | ||
| Q4 24 | $14.1B | $5.0B | ||
| Q3 24 | — | $5.1B | ||
| Q2 24 | — | $5.1B | ||
| Q1 24 | — | $4.4B |
股东权益ABTRGA
| Q4 25 | $52.1B | $13.5B | ||
| Q3 25 | $51.0B | $13.0B | ||
| Q2 25 | $50.6B | $12.1B | ||
| Q1 25 | $48.8B | $11.4B | ||
| Q4 24 | $47.7B | $10.8B | ||
| Q3 24 | $39.8B | $11.1B | ||
| Q2 24 | $39.3B | $9.7B | ||
| Q1 24 | $38.8B | $9.5B |
总资产ABTRGA
| Q4 25 | $86.7B | $156.6B | ||
| Q3 25 | $84.2B | $152.0B | ||
| Q2 25 | $84.0B | $133.5B | ||
| Q1 25 | $81.4B | $128.2B | ||
| Q4 24 | $81.4B | $118.7B | ||
| Q3 24 | $74.4B | $120.3B | ||
| Q2 24 | $73.0B | $109.9B | ||
| Q1 24 | $72.5B | $106.0B |
负债/权益比ABTRGA
| Q4 25 | 0.25× | 0.42× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | 0.30× | 0.47× | ||
| Q3 24 | — | 0.46× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.47× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $7.3B |
| 自由现金流经营现金流 - 资本支出 | $2.6B | — |
| 自由现金流率自由现金流/营收 | 22.9% | — |
| 资本支出强度资本支出/营收 | 6.0% | — |
| 现金转化率经营现金流/净利润 | 1.87× | 15.83× |
| 过去12个月自由现金流最近4个季度 | $7.4B | — |
8季度趋势，按日历期对齐
经营现金流ABTRGA
| Q4 25 | $3.3B | $7.3B | ||
| Q3 25 | $2.8B | $-990.0M | ||
| Q2 25 | $2.0B | $-820.0M | ||
| Q1 25 | $1.4B | $-1.4B | ||
| Q4 24 | $2.9B | $17.1B | ||
| Q3 24 | $2.7B | $-1.1B | ||
| Q2 24 | $2.0B | $-967.0M | ||
| Q1 24 | $1.0B | $-5.7B |
自由现金流ABTRGA
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $933.0M | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $627.0M | — |
自由现金流率ABTRGA
| Q4 25 | 22.9% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 20.2% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 6.3% | — |
资本支出强度ABTRGA
| Q4 25 | 6.0% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.0% | — |
现金转化率ABTRGA
| Q4 25 | 1.87× | 15.83× | ||
| Q3 25 | 1.70× | -3.91× | ||
| Q2 25 | 1.15× | -4.56× | ||
| Q1 25 | 1.07× | -5.00× | ||
| Q4 24 | 0.31× | 115.81× | ||
| Q3 24 | 1.64× | -6.84× | ||
| Q2 24 | 1.51× | -4.76× | ||
| Q1 24 | 0.84× | -27.31× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
